高通量编辑促进了下一代微生物细胞工厂的建设
Xi Sun1, Yangyang Zheng2, Jiancheng Luo2
1School of Life Sciences, Key Laboratory of Ministry of Education for Protection and Utilization of Special Biological Resources in Western China, Ningxia University, Yinchuan, 750021, China.
Synthetic and systems biotechnology
|February 18, 2026
概括
高通量基因组编辑通过实现快速,精确的多基因修改,彻底改变了微生物细胞工厂的发展. 这加速了可持续的生物基生产技术的创建.
科学领域:
- 合成生物学 合成生物学
- 代谢工程是代谢工程.
背景情况:
- 传统的代谢工程与低效的基因编辑,漫长的选和微生物细胞工厂复杂的多基因优化作斗争.
- 开发高效的微生物细胞工厂对于推进可持续的生物基生产至关重要.
研究的目的:
- 审查高通量 (HTP) 基因组编辑机制和微生物代谢工程中的应用.
- 讨论加速微生物细胞工厂 (MCF) 设计建造阶段的HTP策略.
主要方法:
- 审查当前的高通量基因组编辑技术.
- 在代谢途径优化和调节机制研究中对HTP应用的分析.
主要成果:
- HTP基因组编辑精确有效地修改多个基因,克服传统的局限性.
- HTP能够快速选和修改整个代谢途径中的酶和调节因子.
- 惠特普促进了代谢途径的自上而下的分析和自下而上的组装.
结论:
- HTP基因组编辑是构建先进微生物细胞工厂的关键工具.
- 这些进步有望显著提高MCF性能,用于下一代生物生产.
- 在代谢工程中,HTP策略对于加速设计-构建周期至关重要.
相关概念视频
Bioreactor Controls-III
55
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
55
Scale-Up Processes
89
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
89
Upstream Processing
87
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
87


